Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of EXOPULSE Mollii Suit on Spasticity and Muscular Oxygenation in Patients With Multiple Sclerosis.

NCT05912595 is registered in ClinicalTrials.gov with Sheikh Shakhbout Medical City as lead sponsor.

NCT NCT05912595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05912595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of EXOPULSE Mollii Suit on Spasticity and Muscular Oxygenation in Patients With Multiple Sclerosis.
Lead sponsor
Sheikh Shakhbout Medical City
Phase
Not applicable
Overall status
Unknown status
Start date
May 18, 2023
Completion date
July 1, 2024
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ms (multiple sclerosis), oxygen consumption, sclerosis, multiple, spastic, spasticity, muscle